ITGAX and breast carcinoma: Evidence supporting the presence of shared causal variants was obtained through the execution of colocalization analyses, which examined the association between three immune cell types (namely, HLA-DR on plasmacytoid dendritic cells, HLA-DR on dendritic cells, and CD11c+ HLA-DR++ monocyte) and breast cancer.